These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32598932)

  • 41. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
    Lee HS
    Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biphasic MIF and SDF1 expression during podocyte injury promote CD44-mediated glomerular parietal cell migration in focal segmental glomerulosclerosis.
    Ito N; Sakamoto K; Hikichi C; Matsusaka T; Nagata M
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F741-F753. PubMed ID: 32068458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
    Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
    Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
    [No Abstract]   [Full Text] [Related]  

  • 44. MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3.
    Peng R; Zhou L; Zhou Y; Zhao Y; Li Q; Ni D; Hu Y; Long Y; Liu J; Lyu Z; Mao Z; Yuan Y; Huang L; Zhao H; Li G; Zhou Q
    Int J Mol Sci; 2015 Oct; 16(10):24032-47. PubMed ID: 26473838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
    Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
    Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
    Guo N; Guo J; Su D
    Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism.
    Romoli S; Angelotti ML; Antonelli G; Kumar Vr S; Mulay SR; Desai J; Anguiano Gomez L; Thomasova D; Eulberg D; Klussmann S; Melica ME; Conte C; Lombardi D; Lasagni L; Anders HJ; Romagnani P
    Kidney Int; 2018 Dec; 94(6):1111-1126. PubMed ID: 30385042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. For better or worse: a niche for Notch in parietal epithelial cell activation.
    Sweetwyne MT; Susztak K
    Kidney Int; 2013 Jun; 83(6):988-90. PubMed ID: 23728000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection.
    Liu HF; Guo LQ; Huang YY; Chen K; Tao JL; Li SM; Chen XW
    Nephrology (Carlton); 2010 Feb; 15(1):75-83. PubMed ID: 20377774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
    Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
    J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes.
    Barutta F; Kimura S; Hase K; Bellini S; Corbetta B; Corbelli A; Fiordaliso F; Barreca A; Papotti MG; Ghiggeri GM; Salvidio G; Roccatello D; Audrito V; Deaglio S; Gambino R; Bruno S; Camussi G; Martini M; Hirsch E; Durazzo M; Ohno H; Gruden G
    J Am Soc Nephrol; 2021 May; 32(5):1114-1130. PubMed ID: 33722931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
    Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
    Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
    Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
    Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TET2 mediated demethylation is involved in the protective effect of triptolide on podocytes.
    Wan F; Tang YW; Tang XL; Li YY; Yang RC
    Am J Transl Res; 2021; 13(3):1233-1244. PubMed ID: 33841652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
    Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
    J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
    Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
    Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis.
    Wang Y; He Y; Wang M; Lv P; Liu J; Wang J
    Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.